| Sample Size | Type of hyperpigmentation | Protocols | Combined therapy | Results |
---|
Text to translate here | 33 subjects | Melasma or freckles | Skin emulsion with tranexamic acid for 5 to 18 weeks | / | Improvement in pigmentation in 80% of subjects with melasma and 75% with freckles (visual assessment) |
| 2 groups of 30 individuals (n = 60) | Melasma | (1) Micro-injection of tranexamic acid (4 mg/mL) or (2) topical application of a tranexamic acid solution combined with microneedling, 3 times a month for 8 weeks | / | Improvement of 35.72% in the MASI score in the "micro-injection" group compared to 44.41% in the "microneedling" group |
NAEINI F. F. & al. (2014) | 50 Iranian women | Melasma | 3% tranexamic acid topical solution on one side of the face and 3% hydroquinone topical solution on the other side, twice daily for 12 weeks | / | Significant decrease in MASI score in both groups; No significant difference between the two treatments |
HEYDARIAN A. & al. (2017) | 2 groups of 30 individuals (n = 60) | Melasma | (1) Solution with 5% tranexamic acid or (2) 2% hydroquinone solution, twice daily for 12 weeks | / | Reduction in melanin content and MASI score in both groups; No significant difference between the two treatments |
| 84 Chinese individuals (primarily phototypes III or IV) | Moderate to severe facial melasma | Topical application of a poultice containing 2.5% tranexamic acid for about 7 hours once a day for 8 weeks | / | Significant reduction in the MASI score compared to the control group (poultice without TXA) |
ZHENG Q. & al. (2019) | 55 Brazilian individuals | Mild to moderate melasma and/or mild to moderate post-inflammatory hyperpigmentation (PIH) | Topical serum containing 3% tranexamic acid, 1% kojic acid, and 5% niacinamide, twice daily for 12 weeks | In combination with a broad-spectrum sunscreen (preventive care) | Reduction of melanin content by 9% in subjects with melasma and 9.5% in those with PIH |
and | 3 groups of 20 patients (n = 60) | Melasma | (1) Oral administration of 250 mg of TXA twice daily; (2) topical application of TXA; (3) use of the modified Kligman therapeutic solution (2% hydroquinone, 0.05% tretinoin, 0.01% fluocinolone) for 8 weeks | In combination with a broad-spectrum sunscreen (preventive care) | 30% reduction in MASI score with the modified Kligman therapeutic solution, 25% with oral TXA, and 5% with topical TXA |
| 40 individuals (predominantly phototypes IV and V) | Melasma | Topical solution with 10% tranexamic acid (4 sessions spaced 2 weeks apart) | In combination with microneedling + daily application of sunscreen (preventive care) | 65.9% improvement in the mMASI score on the tranexamic acid-treated side compared to 20.7% on the control side (distilled water) |
| 25 subjects | Post-inflammatory hyperpigmentation related to acne | (1) Micro-injection of tranexamic acid (every 2 weeks for 3 months) or (2) fractional CO2 laser (every 4 weeks for 3 months) | / | Significant reduction in HPI for both treatments, with better results from the fractional CO2 laser |
WINN D. & al. (2021) | 35 subjects | Sun damage-related pigment spots | Topical serum with 2% cetyl tranexamate mesylate (ester of tranexamic acid), applied twice daily for 8 weeks | / | Continuous and significant improvement in pigmentation from 2 weeks, reaching a −16.9% change in the melanin index by 8 weeks |
POOSTIYAN E. & al. (2023) | Two groups of 30 subjects with acne vulgaris (n = 60) | Post-inflammatory hyperpigmentation related to acne | (1) Topical cream with 20% azelaic acid or (2) Topical solution with 5% tranexamic acid, twice daily for 12 weeks | / | Decrease in HPI observed in both groups; No significant difference between the two treatments |
LAURENT A. & al. (2024) | 22 Caucasian patients | Facial Hyperpigmentation | Serum with 3% tranexamic acid, 5% niacinamide, and 2% vitamin C derivative + cream with 3% tranexamic acid and 5% niacinamide, twice a day for 8 weeks | / | Significant reduction of 13% in pigmentation intensity and 6% in the size of dark spots |